References

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

10.1001/jama.2013.281053 · ExternalCitation · doi-reference

Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury

10.1001/jama.2020.18618 · ExternalCitation · doi-reference

Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study

10.1007/s00134-015-3934-7 · ExternalCitation · doi-reference

Renal replacement therapy modalities and techniques in intensive care units: an international survey

10.1016/j.jcrc.2025.155076 · ExternalCitation · doi-reference

Low polymorphonuclear cell degranulation during citrate anticoagulation: a comparison between citrate and heparin dialysis

10.1093/ndt/12.7.1387 · ExternalCitation · doi-reference

Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury

10.1097/ccm.0b013e318168c4a4 · ExternalCitation · doi-reference

Citrate anticoagulation for continuous venovenous hemofiltration

10.1097/ccm.0b013e3181953c5e · ExternalCitation · doi-reference

A unified theory of sepsis-induced acute kidney injury

10.1097/shk.0000000000000052 · ExternalCitation · doi-reference

Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta‐analysis of randomized controlled trials

10.1111/1744-9987.13850 · ExternalCitation · doi-reference

Bulk mass transport limitations during high‐flux hemodialysis

10.1111/j.1525-1594.1993.tb00403.x · ExternalCitation · doi-reference

Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration

10.1111/j.1744-9987.2011.00996.x · ExternalCitation · doi-reference

Oxidative stress in the critically ill patients: pathophysiology and potential interventions

10.1155/2018/2353128 · ExternalCitation · doi-reference

Fouling of ultrafiltration and hemodialysis membranes by plasma proteins

10.1159/000170177 · ExternalCitation · doi-reference

Lung–kidney cross-talk in the critically ill patient

10.1164/rccm.201602-0420cp · ExternalCitation · doi-reference

From ICU syndromes to ICU subphenotypes: consensus report and recommendations for developing precision medicine in the ICU

10.1164/rccm.202311-2086so · ExternalCitation · doi-reference

Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients

10.1186/1471-2369-15-19 · ExternalCitation · doi-reference

Paradigm shifts in critical care medicine: the progress we have made

10.1186/cc14728 · ExternalCitation · doi-reference

Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial

10.1186/s13054-014-0472-6 · ExternalCitation · doi-reference

Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial

10.1186/s13054-015-0822-z · ExternalCitation · doi-reference

Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials

10.1186/s13054-016-1299-0 · ExternalCitation · doi-reference

Complications of regional citrate anticoagulation: accumulation or overload

10.1186/s13054-017-1880-1 · ExternalCitation · doi-reference

The challenge of removal of sepsis markers by continuous hemofiltration

10.1186/s13054-019-2464-z · ExternalCitation · doi-reference

Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not

10.1186/s13054-020-03277-8 · ExternalCitation · doi-reference

Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials

10.1186/s13054-023-04519-1 · ExternalCitation · doi-reference

The phenomenon of desorption: what are the best adsorber exchange intervals

10.1186/s13054-024-04968-2 · ExternalCitation · doi-reference

Desorption in hemoadsorption therapies: a call for more data

10.1186/s13054-024-04995-z · ExternalCitation · doi-reference

Renal replacement therapy in ICU: from conservative to restrictive strategy

10.1186/s13054-025-05271-4 · ExternalCitation · doi-reference

Unapparent systemic effects of regional anticoagulation with citrate in continuous renal replacement therapy: a narrative review

10.1186/s13613-023-01113-0 · ExternalCitation · doi-reference

Effects of storage conditions on oxidative stress biomarkers: methodological implications for ecological and evolutionary studies

10.1242/jeb.251748 · ExternalCitation · doi-reference

Regional citrate anticoagulation for RRTs in critically ill patients with AKI

10.2215/cjn.01280214 · ExternalCitation · doi-reference

Organ crosstalk in acute kidney injury: evidence and mechanisms

10.3390/jcm11226637 · ExternalCitation · doi-reference

21st century critical care medicine: an overview

10.5492/wjccm.v13.i1.90176 · ExternalCitation · doi-reference

Sepsis-associated acute kidney injury: pathophysiology and treatment modalities

10.7759/cureus.75992 · ExternalCitation · doi-reference